Zhenzhen Zhao

Ms. Zhenzhen Zhao


Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
28 January 2025 in Frontiers in Immunology
Verified
Journal Article
Open access
PDF file
LSLei Sun
Lei Sun
JZJinhao Zhang
Jinhao Zhang
ZXZhikai Xiahou
Zhikai Xiahou
ZZZhenzhen Zhao
Zhenzhen Zhao
YLYanchen Liang
Yanchen Liang
Background: Osteosarcoma (OS) is one of the most common primary malignant bone tumors, primarily originating from mesenchymal tissue. It is notorious for its high invasiveness, high disability rate, high mortality rate, and poor prognosis. In most primary and metastatic malignant tumors, bone destruction can promote cancer progression, which is closely related to osteoclast activation and the imbalance between osteoblasts and osteoclasts. A large number of studies confirmed that osteoclasts are an important part of OS, which play an active role in destroying bone homeostasis and promoting the progress of OS. Therefore, we conducted a detailed study of osteoclasts at the single cell level, aiming to find new OS therapeutic targets to prevent tumor progression and local spread.Methods: We analyzed the single-cell sequencing data of OS patients and usedMonocle2, Cytotrace, and Slingshot software to analyze the pseudo-sequential trajectory during OS progression. CellChat was used to reveal the communication between cells. PySCENIC was used to identify active transcription factors in osteoclasts. Finally, we further demonstrated the results by RT-qPCR analysis, CCK-8 assay, wound healing assay, Transwell assay, etc.Results: Through the analysis of single-cell sequencing data in OS, we identified a highly specific subgroup, C2MKI67+ Osteoclast. The key signaling pathway APP and the top 1 transcription factor PPARG in this subgroup played essential roles in osteoclast proliferation and differentiation. Given the pivotal role of osteoclasts in OS progression, we speculated that these signaling pathways and transcription factors could emerge as novel therapeutic targets, offering innovative strategies for OS treatment.Conclusion: This study enhanced our understanding of OS and osteoclasts through scRNA-seq. Furthermore, we discovered that PPARG amplifies osteoclast activation and proliferation, resulting in excessive bone resorption and degradation of the bone matrix, thereby creating a favorable environment for tumor cell proliferation and growth. By innovatively targeting PPARG, it affected osteoclast proliferation and thus affected tumor progression; this work offered new insights and directions for the clinical treatment of OS patients.

14 October 2025 in Journal of Nanobiotechnology
Verified
Journal Article
Open access
PDF file
DCDi Chen
Di Chen
HJHui Jiang
Hui Jiang
LSLu Sun
Lu Sun
YNYeltai Nurzat
Yeltai Nurzat
HQHaocheng Qin
Haocheng Qin
SLShaohua Li
Shaohua Li
Ischemic stroke triggers the “ischemic cascade,” which encompasses vascular injury, oxidative stress, inflammatory responses, and mitochondrial dysfunction, ultimately leading to neuronal death and impaired brain function. Conventional pharmacotherapies have specific limitations, such as being restricted by the blood–brain barrier (BBB), causing systemic side effects, and having poor lesion targeting. To tackle the aforementioned challenges, this study developed PUELipo/R-R, a safe and highly biocompatible liposome nanocarrier modified with reactive oxygen species (ROS)-responsive DSPE-TK-PEG and neuron-targeting RVG29 peptide on the surface, for the precise delivery of puerarin (PUE) to ischemic brain regions and the release of stimuli-responsive drugs. PUE demonstrates the advantage of multi-target regulation in treating ischemic stroke. In a mouse model of middle cerebral artery occlusion/reperfusion (MCAO/r), PUELipo/R-R significantly reduced the volume of cerebral infarction, decreased neuronal death rate, and improved post-stroke motor function. The results of single-cell RNA sequencing (scRNA-seq) revealed that endothelial cells (ECs) and microglia were the cell types with the most significant alterations in the experimental group treated with PUELipo/R-R. Both in vitro and in vivo studies have verified that PUELipo/R-R enhances the expression levels of angiogenesis-related factors, promotes the proliferation, migration, and angiogenesis of cerebrovascular ECs, and improves neuroinflammatory conditions by facilitating the transformation of microglia from the pro-inflammatory M1 phenotype to the anti-inflammatory M2 phenotype. This novel multi-target therapeutic strategy highlights the potential application of PUELipo/R-R as a possible treatment for ischemic stroke and related disorders.

24 December 2024 in Translational Oncology
Verified
Journal Article
Open access
CDChen Ding
Chen Ding
JWJiange Wang
Jiange Wang
JWJie Wang
Jie Wang
JNJiqiang Niu
Jiqiang Niu
ZXZhikai Xiahou
Zhikai Xiahou
DZDongyang Zeng
Dongyang Zeng
Prostate cancer stands as the second most common malignancy among men, notorious for its intricate heterogeneity, especially evident in metastatic disease. This complexity presents substantial challenges in treatment efficacy and patient prognosis. This study endeavors to elucidate the multifaceted roles of cancer-associated fibroblasts within the tumor microenvironment of prostate cancer, with a focus on their implications for disease prognosis and the potential for novel immunotherapeutic strategies. Leveraging advanced single-cell RNA sequencing technology, we meticulously characterized the diverse CAF subpopulations within prostate cancer samples. Our analysis identified four predominant subsets: C0 IER2+, C1 ABCA8+, C2 ABI3BP+, and C3 MEOX2+. We conducted comprehensive gene expression profiling to construct a robust prognostic model reflecting the clinical relevance of these subpopulations. C1 ABCA8+ fibroblasts demonstrated heightened proliferative activity, underscoring their pivotal role in fostering tumor growth and metastasis via intricate signaling pathways. In vitro experiments verified that the T transcription factor NFAT5 of C1 ABCA8+ fibroblasts subpopulation was knocked down in LNCaP clone FGC and 22Rv1 cell lines, which was closely related to the proliferation of PC. Moreover, we identified key genes linked to patient outcomes and immune landscape alterations, reinforcing the prognostic significance of CAF characteristics in this context. This investigation illuminates the critical potential of targeting CAFs to augment immunotherapeutic approaches in prostate cancer. Our findings contribute to a deeper understanding of the TME's complexity, advocating for further exploration into CAF-targeted therapies aimed at enhancing treatment responses and ultimately improving patient outcomes.

1 January 2024 in Open Medicine
Verified
Journal Article
Open access
PDF file
ZZZhenzhen Zhao
Zhenzhen Zhao
YQYuelong Qin
Yuelong Qin
RWRui Wu
Rui Wu
WLWenwu Li
Wenwu Li
YDYujiang Dong
Yujiang Dong
Background: Atherosclerosis is a lipid-driven inflammatory disease characterized by plaque formation in major arteries. These plaques contain lipid-rich macrophages that accumulate through monocyte recruitment, local macrophage differentiation, and proliferation. Objective: We identify the macrophage subsets that are closely related to atherosclerosis and reveal the key pathways in the progression of atherosclerotic disease. Materials and methods: In this study, we characterize the single-cell landscape of atherosclerosis, identifying macrophage subsets closely related to the disease and revealing key pathways in its progression. Using analytical methods like CytoTRACE, Monocle2, Slingshot, and CellChat, we study macrophage differentiation and infer cell trajectory. Results: The 8,417 macrophages were divided into six subtypes, macrophages: C0 C1QC+ macrophages, C1 SPP1+ macrophages, C2 FCN1+ macrophages, C3 IGKC+ macrophages, C4 FCER1A+ macrophages, C5CALD1+ macrophages. The results of gene set enrichment analysis, Monocle2, and Slingshot suggest that C2 FCN1+ macrophages may play an important role in the progression of atherosclerosis. C2 FCN1+ macrophages interact with endothelial cells via CCL, CXCL, APP, and other pathways to regulate the progression of atherosclerosis. Conclusion: We identify a key macrophage subgroup (C2 FCN1+ macrophages) associated with atherosclerosis, which interacts with endothelial cells via CCL, CXCL, APP, and other pathways to regulate disease progression.

6 March 2025 in Frontiers in Immunology
Verified
Journal Article
Open access
PDF file
GNGaofeng Ni
Gaofeng Ni
XLXinhan Li
Xinhan Li
WNWenyang Nie
Wenyang Nie
ZZZhenzhen Zhao
Zhenzhen Zhao
HLHua Li
Hua Li
HZHongyan Zang
Hongyan Zang
Background: Breast Cancer (BC) ranks among the top three most prevalent cancers globally and stands as the principal contributor to cancer-related fatalities among women. In spite of the substantial occurrence rate of BC, the early stage of this disease is generally regarded as curable. However, intra-tumor heterogeneity presents a formidable obstacle to the success of effective treatment. Method: In this research, single cell RNA sequencing was utilized to dissect the tumor microenvironment within BC. Slingshot, CytoTRACE and Monocle 2 were applied to illustrate the differentiation process of each subpopulation in the pseudotime sequence. To comprehensively comprehend the tumor cells (TCs) in BC, an analysis of upstream transcription factors was carried out via pySCENIC, while downstream pathway enrichment was conducted through KEGG, GO and GSEA. The prognosis model was established based on the bulk data obtained from TCGA and GEO databases. Knock-down experiments were also implemented to explore the function of the transcription factor CEBPD in the TCs. Results: Our in-depth analysis identified eight principal cell types. Notably, TCs were predominantly found within epithelial cells. The classification of TCs further uncovered five unique subpopulations, with one subpopulation characterized by high UGDH expression. This subpopulation was shown to possess distinct metabolic features in metabolism-related investigations. The intricate communication modalities among different cell types were effectively demonstrated by means of CellChat. Additionally, a crucial transcription factor, CEBPD , was identified, which demonstrated a pronounced propensity towards tumors and harbored potential tumor-advancing characteristics. Its role in promoting cancer was subsequently verified through in vitro knock-down experiments. Moreover, a prognostic model was also developed, and a risk score was established based on the genes incorporated in the model. Through comparing the prognoses of different UTRS levels, it was determined that the group with a high UTRS had a less favorable prognosis. Conclusion: These outcomes contributed to the elucidation of the complex interrelationships within the BC tumor microenvironment. By specifically targeting certain subpopulations of TCs, novel treatment strategies could potentially be devised. This study shed light on the direction that future research in BC should take, furnishing valuable information that can be utilized to enhance treatment regimens.

25 February 2026 in Clinical and Experimental Medicine
Verified
Journal Article
Open access
PDF file
ZZZhenzhen Zhao
Zhenzhen Zhao
ZZZhijie Zhao
Zhijie Zhao
HJHongling Jia
Hongling Jia
YQYuelong Qin
Yuelong Qin
ZXZhikai Xiahou
Zhikai Xiahou
WLWenwu Li
Wenwu Li
Atherosclerosis is a complex chronic inflammatory disease characterized by lipid accumulation, vascular smooth muscle cell (VSMCs) proliferation, and immune cell infiltration. However, the heterogeneity and functional dynamics of VSMCs in atherosclerotic lesions have not been systematically elucidated. In this study, we integrated single-cell transcriptomics with spatial transcriptomics analysis to delineate the developmental trajectories and functional states of VSMC subsets. Our analysis identified a distinct LUM + VSMCs subpopulation residing at an early stage of differentiation, marked by elevated cellular plasticity, stemness features, and strong activation of pro-inflammatory signaling pathways. Spatial transcriptomics and in vitro functional assays—including EdU incorporation, apoptosis quantification, and cell viability assays—further validated LUM as a key regulator promoting VSMC proliferation and inflammation. Importantly, the C0 LUM + VSMCs were predicted to interact extensively with endothelial cells and macrophages through CD99, MIF, and CCL-mediated signaling axes, underscoring their role as dedifferentiated, pro-inflammatory effector cells contributing to disease progression. These findings highlight the power of big data-enabled single-cell approaches in identifying cell-type–specific mechanisms and offer new avenues for precision diagnostics and biomarker discovery in inflammatory vascular diseases.